Trials / Completed
CompletedNCT04227171
Observational Study to Develop Dosing Chart
A Multicenter, Prospective Cohort Observational Study to Develop Dosing Chart Based on Patient Specific Characteristics and Ovarian Response When Follitrope™ PFS is Administered Subcutaneously to Infertility Women Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 534 (actual)
- Sponsor
- LG Chem · Industry
- Sex
- Female
- Age
- 19 Years – 39 Years
- Healthy volunteers
- Accepted
Summary
To confirm the predictors based on patient specific characteristics and ovarian response and develop dosing chart when Follitrope™ PFS is administered to infertility women patients.
Conditions
Timeline
- Start date
- 2018-08-03
- Primary completion
- 2020-07-31
- Completion
- 2020-07-31
- First posted
- 2020-01-13
- Last updated
- 2020-08-07
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04227171. Inclusion in this directory is not an endorsement.